Cybin (TSE:CYBN) has released an update.
Cybin Inc., a clinical-stage company focused on developing innovative treatments for mental health, has completed a share consolidation which reduces the number of outstanding shares from approximately 759 million to just under 20 million. This consolidation is intended to enhance the company’s stock market presence and does not alter shareholder’s percentage ownership, except for minor adjustments due to fractional shares.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
